illegal phenibut sold brand names anvifen fenibut noofen among central nervous system depressant anxiolytic effects used treat anxiety insomnia variety usually taken mouth tablet may given side effects phenibut include sedation sleepiness nausea irritability agitation dizziness euphoria reduction anxiety sometimes headache among overdose phenibut produce marked central nervous system depression including medication structurally related neurotransmitter γaminobutyric acid gaba hence gaba phenibut thought act gabab receptor agonist similarly baclofen γhydroxybutyrate however low concentrations phenibut mildly increases concentration dopamine brain providing stimulatory effects addition phenibut developed soviet union introduced medical use today marketed medical use russia ukraine belarus kazakhstan medication approved clinical use united states europe also sold internet supplement purported phenibut used recreationally produce euphoria well addiction dependence controlled substance australia suggested legal status reconsidered europe phenibut used russia ukraine belarus latvia pharmaceutical drug treat anxiety improve sleep eg treatment also used various indications including treatment asthenia depression alcoholism alcohol withdrawal syndrome posttraumatic stress disorder stuttering tics vestibular disorders ménières disease dizziness prevention motion sickness prevention anxiety surgical procedures painful diagnostic phenibut available medication form mg mg tablets oral administration solution concentration mgml us dietary supplements labeled containing phenibut found contain zero greater mg phenibut per contraindications phenibut phenibut combined phenibut generally possible side effects may include sedation somnolence nausea irritability agitation anxiety dizziness headache allergic reactions skin rash high doses motor incoordination loss balance hangovers may due central nervous system depressant effects people taking phenibut refrain potentially dangerous activities operating heavy prolonged use phenibut particularly high doses liver blood monitored due risk fatty liver disease overdose phenibut cause severe drowsiness nausea vomiting eosinophilia lowered blood pressure renal impairment grams fatty liver specific antidotes phenibut lethargy somnolence agitation delirium seizures reduced consciousness unconsciousness unresponsiveness reported recreational users management phenibut overdose includes activated charcoal gastric lavage induction vomiting symptombased three associated deaths found phenibut users system one cases singlehandedly included tolerance phenibut easily develops repeated use leading update withdrawal symptoms may occur upon discontinuation recreational users taking high doses reported include severe rebound anxiety insomnia anger irritability agitation visual auditory hallucinations acute baclofen successfully used treatment phenibut phenibut may mutually potentiate extend duration effects central nervous system depressants including anxiolytics antipsychotics sedatives opioids anticonvulsants phenibut acts full agonist gabab receptor similarly lower affinity gabab receptor baclofen accordance used far higher doses rphenibut higher affinity gabab receptor sphenibut hence rphenibut active enantiomer gabab phenibut also binds blocks subunitcontaining vdccs similarly gabapentin pregabalin hence rphenibut sphenibut display action similar affinity ki μm little information thus far published clinical pharmacokinetics drug reported distributes widely throughout body across approximately administered dose phenibut reportedly penetrates brain said occur much greater extent young people following single mg dose healthy volunteers elimination halflife approximately hours drug largely excreted urine limited information described pharmacokinetics phenibut recreational users taking much higher doses eg grams typical clinical individuals onset action phenibut reported hours orally minutes rectally peak effects described occurring hours following oral ingestion total duration oral route reported hours terminal phenibut synthetic aromatic amino acid chiral molecule thus two potential configurations r phenibut derivative inhibitory neurotransmitter hence gaba phenibut specifically analogue gaba phenyl ring substituted chemical name βphenylγaminobutyric acid abbreviated presence phenyl ring allows phenibut cross barrier significantly unlike case phenibut also contains trace amine βphenethylamine phenibut closely related variety gaba analogues including baclofen tolibut pregabalin sβisobutylgaba gabapentin acetic acid gabob almost chemical structure baclofen differing hydrogen atom instead chlorine atom para position phenyl phenibut also close structure pregabalin isobutyl group β position instead phenibuts phenyl glutamatederivative analogue phenibut glufimet dimethyl chemical synthesis phenibut phenibut synthesized herzen leningrad pedagogical institute ussr professor vsevolod perekalins team tested institute experimental medicine ussr academy medical introduced clinical use russia alternate spellings include fenibut also sometimes referred aminophenylbutyric word phenibut contraction chemical name drug βphenylγaminobutyric early publications phenibut referred fenigam drug assigned inntooltip international nonproprietary phenibut marketed russia ukraine belarus latvia brand names anvifen fenibut bifren noofen russian анвифен фенибут бифрен ноофен phenibut approved russia ukraine belarus latvia medical approved available medication countries european union united states countries phenibut licensed pharmaceutical drug sold online without prescription nutritional often used form selfmedication social phenibut used recreationally due ability produce euphoria anxiolysis increased well remaining undetected routine urinalysis delayed onset effects firsttime users often mistakenly take additional dose phenibut belief initial dose recreational users usually take drug orally case reports rectal administration one report insufflation described painful causing swollen phenibut controlled substance suggested legal status phenibut europe reconsidered due recreational february australian therapeutic goods administration declared prohibited schedule substance citing health concerns due withdrawal november hungary added phenibut items new psychoactive substances ban august italy added phenibut new psychoactive substances ban september france added phenibut controlled psychoactive substances list prohibiting production sale storage united states phenibut controlled substance however dietary supplements contain phenibut unlawful introduce interstate commerce phenibut considered new drug food supplement cosmetic drug contains phenibut therefore misbranded alabama scheduled phenibut tianeptine first action alabama department public health followed state httpsenwikipediaorgwikiphenibut